HR Execs on the Move

Lane Individual Practice Association

www.lipa.net

 
Lane Individual Practice Association is a Eugene, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Elevate ENT Partners

ELEVATE ENT Partners is a practice management support organization that provides private ear, nose, and throat (ENT) practices with the business support, capital, and resources they need to provide focused, quality care to their patients, grow their pr...

Vention Medical

Vention Medical is a South Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Catholic Health

Our commitment is well-established, so we decided to shorten our name. Catholic Health Services of Long Island is now Catholic Health.

Synedgen

Synedgen is a Claremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.